Scientists Solve the Crystal Structure of the Fumarate Salts of DMT and Psilocin Derivatives
This new knowledge provides more options for developing psychedelics into therapeutic drug formulations.
Pharmaceuticals - Page 4
Johns Hopkins Starts Psilocybin Clinical Trial to Treat Anorexia Nervosa
Anorexia has phenomenological parallels to anxiety and addiction, both of which have been shown to improve with psilocybin-assisted interventions.
Researchers Present a New Crystal Structure of Psilacetin, An Alternative Prodrug of Psilocin
Psilacetin is less expensive and easier to make than psilocybin.
Is Esketamine the First FDA-Approved Psychedelic Drug?
The answer is yes and no. It's a matter of perspective.
TheraPsil Seeks Permission From Health Canada to Use Psilocybin Treatments for Dying Patients
Bruce Tobin is asking Health Canada to approve psilocybin to treat anxiety and depression in end-of-life patients.